Yaping Yang

机构：Sun Yat-sen University, Sun Yat-sen Memorial Hospital, Guangzhou Medical University

发表论文 27 篇 · 总被引 65 次 · h-index 4

代表论文

Dynamic ctDNA tracking stratifies relapse risk for triple negative breast cancer patients receiving neoadjuvant chemotherapy (2025 · Nature Communications · 被引 24)
First-in-human study of JSKN016, a bispecific anti-TROP2/HER3 antibody drug conjugate (ADC): Antitumor activity in patients (pts) with metastatic triple-negative breast cancer (mTNBC) and safety results. (2025 · Journal of Clinical Oncology · 被引 9)
FG-M108 plus nab-paclitaxel and gemcitabine (AG) as first-line (1L) treatment for patients with Claudin-18.2 (CLDN18.2) positive locally advanced unresectable or metastatic pancreatic cancer (PC): Preliminary results from the phase 1b study. (2024 · Journal of Clinical Oncology · 被引 5)
Development and validation of a nomogram for predicting the occurrence of renal dysfunction after treatment of immune checkpoint inhibitor: a retrospective case–control study (2024 · BMJ Open · 被引 4)
Sequential neoadjuvant chemotherapy using pegylated liposomal doxorubicin and cyclophosphamide followed by taxanes with complete trastuzumab and pertuzumab treatment for HER2-positive breast cancer: A phase II single-arm study (2024 · Chinese Journal of Cancer Research · 被引 4)
FG-M108 plus capecitabine and oxaliplatin (CAPOX) for ﬁrst-line treatment of CLDN18.2+/HER2- advanced gastric/gastroesophageal junction adenocarcinoma (GC): Update results of a phase I/II trial to determine RP2D. (2025 · Journal of Clinical Oncology · 被引 3)